Introducing Thine: A Personal Intelligence With Real Privacy at Its Core

SAN FRANCISCO, Dec. 10, 2025 (GLOBE NEWSWIRE) — Modern life moves faster than the mind can keep up with. People make decisions, shift priorities, hold complex conversations and process signals all day long, yet rarely have the bandwidth to see the bigger picture. Thine was created for this reality. Built by tech company Foyer, Thine […]

Lexicon Pharmaceuticals Announces Publication of Preclinical Data in the Journal of the Endocrine Society on Acyl-CoA Synthetase 5 (ACSL5) Reinforcing the Scientific Rationale for LX9851

(NASDAQ:LXRX), THE WOODLANDS, Texas, Dec. 10, 2025 (GLOBE NEWSWIRE) — Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced the publication of preclinical data validating Acyl-CoA Synthetase 5 (ACSL5) as a target for obesity and chronic weight management. The paper, titled “Acyl-CoA Synthetase 5 knockout and inhibitors protect against diet-induced obesity in mice by activating the ileal

Veru to Report Fiscal Year 2025 Financial Results on December 17th

(NASDAQ:VERU), MIAMI, FL, Dec. 10, 2025 (GLOBE NEWSWIRE) — Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on developing innovative medicines for the treatment of cardiometabolic and inflammatory diseases, today announced it will host a conference call and audio webcast on Wednesday, December 17, 2025, at 8:00 a.m. ET to discuss its

IQSTEL Announces 2025 Accomplishments and Strategic Priorities for 2026 in New Interview

(NasdaqGM:IQST),(NasdaqGM:CYCU), 2025 Achievements Lay Foundation for Accelerated 2026 Expansion NEW YORK, Dec. 10, 2025 (GLOBE NEWSWIRE) — IQSTEL Inc. (NASDAQ: IQST) (“IQSTEL”), a leading provider of innovative telecommunications and technology solutions, today announced highlights from its 2025 performance in a yearâ€'end executive interview, underscoring achievements that have positioned the company for accelerated growth in 2026.

IODeFi Unveils Breakthrough Passive-Income App for BTC & ETH Holders — New Automated Yield Engine Officially Launched Today

Stanmore, England, Dec. 10, 2025 (GLOBE NEWSWIRE) — IODeFi introduces its newly upgraded Automated Yield App, enabling BTC and ETH holders to earn daily payouts through a fully automated, hardware-free reward engine. Bitcoin (BTC) and Ethereum (ETH) remain the world's most trusted digital assets–but millions of holders struggle with the same issue: how to earn

Virginia Beach Teams with eleven-x to Deploy Data-Driven eXactpark Smart Parking Initiative

WATERLOO, Ontario, Dec. 10, 2025 (GLOBE NEWSWIRE) — eleven-x(R), a leader in smart parking and curbside management solutions, today announced a smart parking initiative with the City of Virginia Beach, VA which is designed to improve the parking experience for drivers while helping parking managers understand how their parking is being used. With the recent

PharmAla Biotech Completes Release Testing on Australian-Made LaNeo Capsules

(CNSX:MDMA.CN),(CNSX:MDMA),(OTC US:MDXXF),(Other OTC:MDXXF), TORONTO, Dec. 10, 2025 (GLOBE NEWSWIRE) — PharmAla Biotech Holdings Inc. (“PharmAla” or the “Company“) (CSE: MDMA) (OTC:MDXXF), a biotechnology company focused on the research, development, and manufacturing of novel MDXX class molecules (including its LaNeo(TM) MDMA), is excited to announce that it has completed release testing of its first Australian-made batch

Hyve Managed Hosting Wins Greater Austin Business Award for Technology Innovation

AUSTIN, Texas, Dec. 10, 2025 (GLOBE NEWSWIRE) — Hyve Managed Hosting, a global provider of managed hosting solutions, has been named the winner of the 2025 Technology Innovation Award at the Greater Austin Business Awards. Chosen from 10 nominated companies, this award represents one of the highest forms of business recognition in Greater Austin, highlighting

PainReform Confirms the Ability of Its LayerBio Drop-Less Sustained-Release Ocular Platform to Accommodate Multiple Drug Entities

PainReform Confirms the Ability of Its LayerBio Drop-Less Sustained-Release Ocular Platform to Accommodate Multiple Drug Entities R&D assessment shows the platform can incorporate different drug entities onto its sustained-release matrix, supporting long-term potential to reduce or eliminate reliance on medicated eye drops GlobeNewswire December 10, 2025 TEL AVIV, Israel, Dec. 10, 2025 (GLOBE NEWSWIRE) —

Moleculin Announces Exercise of Warrants for $6.8 Million Gross Proceeds

Moleculin Announces Exercise of Warrants for $6.8 Million Gross Proceeds GlobeNewswire December 10, 2025 HOUSTON, Dec. 10, 2025 (GLOBE NEWSWIRE) — Moleculin Biotech, Inc., (Nasdaq: MBRX) (“Moleculin” or the “Company”), a late-stage pharmaceutical company with a broad portfolio of drug candidates targeting hard-to-treat tumors and viruses, today announced it has entered into agreements with certain

Scroll to Top